Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gingival Bleeding in a Child with Fanconi Anemia: A Case Report and Literature Review. | Case Rep Dent | 2020 | 32231808 | PubTator, text mining | PubMed |
| Landscape of BRIP1 molecular lesions in gastrointestinal cancers from published genomic studies. | World J Gastroenterol | 2020 | 32231423 | PubTator, text mining | PubMed |
| Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer. | Theranostics | 2020 | 32226530 | PubTator, text mining | PubMed |
| Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond. | Drugs R D | 2020 | 32215876 | PubTator, text mining | PubMed |
| Mesothelioma developing in carriers of inherited genetic mutations. | Transl Lung Cancer Res | 2020 | 32206572 | PubTator, text mining | PubMed |
| Fanconi anemia pathway as a prospective target for cancer intervention. | Cell Biosci | 2020 | 32190289 | PubTator, text mining | PubMed |
| Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. | Eur Urol Oncol | 2020 | 32165095 | PubTator, text mining | PubMed |
| Resolving Binding Events on the Multifunctional Human Serum Albumin. | ChemMedChem | 2020 | 32162429 | PubTator, text mining | PubMed |
| A Genome-wide ER-phagy Screen Highlights Key Roles of Mitochondrial Metabolism and ER-Resident UFMylation. | Cell | 2020 | 32160526 | PubTator, text mining | PubMed |
| Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known Therapies. | Geburtshilfe Frauenheilkd | 2020 | 32139917 | PubTator, text mining | PubMed |
| Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. | Lancet Oncol | 2020 | 32135080 | PubTator, text mining | PubMed |
| Precision oncology in urothelial cancer. | ESMO Open | 2020 | 32132102 | PubTator, text mining | PubMed |
| Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations. | Pract Lab Med | 2020 | 32123717 | PubTator, text mining | PubMed |
| ATR-Mediated FANCI Phosphorylation Regulates Both Ubiquitination and Deubiquitination of FANCD2. | Front Cell Dev Biol | 2020 | 32117957 | PubTator, text mining | PubMed |
| A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants. | EBioMedicine | 2020 | 32113160 | PubTator, text mining | PubMed |
| Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies. | Oncotarget | 2020 | 32110280 | PubTator, text mining | PubMed |
| Preparation and purification of mono-ubiquitinated proteins using Avi-tagged ubiquitin. | PLoS One | 2020 | 32092106 | PubTator, text mining | PubMed |
| Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee. | Cancer Med | 2020 | 32087612 | PubTator, text mining | PubMed |
| Personalized Assessment of Normal Tissue Radiosensitivity via Transcriptome Response to Photon, Proton and Carbon Irradiation in Patient-Derived Human Intestinal Organoids. | Cancers (Basel) | 2020 | 32085439 | PubTator, text mining | PubMed |
Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial. | Contemp Clin Trials Commun | 2020 | 32083220 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=58